Sustaining Generic Medicines Markets in Europe

More documents

Recommendations

Info

Sustaining generic medicines markets 24selection of less risky patients if they do not take into account patient profiles or do not cover acomprehensive range of health care services. Significantly, there is a high rate of confidence andacceptance of generic medicines among both physicians and patients mainly due to well-knowncompany branding of generic medicines.Demand for generic medicines is supported by generic substitution by pharmacists. Furthermore,conditions governing substitution have been losened from physicians having to allow substitutionto physicians opposed to substitution having to forbid it. The former incentive not to substitute hasthereby been removed. However, pharmacists are financially penalised for dispensing genericmedicines.Key factors aiding the development of the generic medicines market:• Market entry of generic medicines benefits from a RPS that sets higher RPs in medicinegroups with fewer generic competitors and that stimulates price competition, but still makes itpossible for generic medicines companies to earn profits• Demand for generic medicines is driven by generic substitution by pharmacists and byphysician budgets in combination with prescription targets and feedback on prescribingbehaviourKey factors hindering the development of the generic medicines market:• Pharmacists are financially penalised for dispensing generic medicines
Sustaining generic medicines markets 254 Netherlands4.1 Generic medicines marketThe Dutch generic medicines market has grown rapidly over time, with public expenditureincreasing from 185 million € in 1994 (market share by value of 8.5%) to 830 million € in 2004(market share of 17.7%). The fall in market share of generic medicines by value between 2003and 2004 is likely to originate from a 2004 policy that substantially reduced prices of genericmedicines. Market share of generic medicines by volume has more than doubled from 19.9% in1994 to 44.3% in 2004.Figure 3. Market share of generic medicines by value in the Netherlands, 1994-2004Market share of generic medicines100%80%60%40%20%0%8,5%8,9%8,9%9,8%10,8%12,0%13,5%14,2%17,9%21,9%17,7%1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004YearFigure 4. Market share of generic medicines by volume in the Netherlands, 1994-2004Market share of generic medicines100%80%60%40%20%0%43,1%39,6%44,3%34,7% 35,9%28,9%33,0%25,3% 27,1%19,9% 22,6%1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004Year
Page 4: Sustaining generic medicines market
Page 13: Sustaining generic medicines market
Page 16 and 17: Sustaining generic medicines market
Page 76 and 77:
Sustaining generic medicines market
Page 78 and 79:
Page 80 and 81:
Page 82 and 83:
Page 84 and 85:
Page 86 and 87:
Page 88 and 89:
Page 90 and 91:
Page 92 and 93:
Page 94 and 95:
Page 96 and 97:
Page 98 and 99:
Page 100 and 101:
Page 102 and 103:
Page 104 and 105:
Page 106:
Generic medicines create major savi
show all

Sustaining Generic Medicines Markets in Europe

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?